| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 191.38B | 192.49B | 193.83B | 178.62B | 163.54B | 152.00B |
| Gross Profit | 40.66B | 40.89B | 41.34B | 34.25B | 36.63B | 33.89B |
| EBITDA | 27.10B | 28.92B | 27.52B | 21.12B | 21.79B | 24.15B |
| Net Income | 8.60B | 8.87B | 8.20B | 3.84B | 8.09B | 5.47B |
Balance Sheet | ||||||
| Total Assets | 282.31B | 291.78B | 290.11B | 264.70B | 255.40B | 244.06B |
| Cash, Cash Equivalents and Short-Term Investments | 58.64B | 62.46B | 52.01B | 45.35B | 40.79B | 42.37B |
| Total Debt | 26.92B | 33.57B | 35.65B | 40.14B | 38.94B | 45.58B |
| Total Liabilities | 90.45B | 93.14B | 100.47B | 98.80B | 95.64B | 100.92B |
| Stockholders Equity | 158.59B | 162.95B | 157.50B | 133.90B | 128.94B | 116.38B |
Cash Flow | ||||||
| Free Cash Flow | 3.40B | 13.00B | 14.23B | 11.63B | 8.58B | 6.91B |
| Operating Cash Flow | 5.44B | 21.74B | 24.39B | 21.09B | 19.86B | 16.25B |
| Investing Cash Flow | -2.81B | -4.58B | -9.61B | -14.57B | -13.44B | -9.38B |
| Financing Cash Flow | -1.54B | -9.93B | -10.55B | -3.92B | -10.35B | -11.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥85.26B | 10.30 | ― | 3.85% | -4.47% | 29.68% | |
75 Outperform | ¥504.17B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
74 Outperform | ¥531.96B | 11.33 | ― | 2.60% | 1.06% | -5.99% | |
73 Outperform | ¥134.14B | 16.04 | ― | 5.78% | -4.26% | 17.85% | |
66 Neutral | ¥441.34B | 10.02 | 3.70% | 3.42% | 2.10% | -50.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥3.52B | 10.35 | ― | 3.03% | 4.17% | -693.96% |